NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors-Reference-Cited by-同舟云学术

NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors

Published:2019-08-28 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Phi Ji Hoon,Sun Choong-Hyun,Lee Se-Hoon,Lee Seungmook,Park Inho,Choi Seung Ah,Park Sung-Hye,Lee Ji Yeoun,Wang Kyu-Chang,Kim Seung-Ki,Yun Hongseok,Park Chul-Kee^ORCID

Funder

National Research Foundation of Korea

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-6044-z.pdf

Reference60 articles.

1. von Hoff K, Hinkes B, Dannenmann-Stern E, von Bueren AO, Warmuth-Metz M, Soerensen N, Emser A, Zwiener I, Schlegel PG, Kuehl J, et al. Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer. 2011;57(6):978–85.

2. Lee JY, Kim IK, Phi JH, Wang KC, Cho BK, Park SH, Ahn HS, Kim IH, Kim SK. Atypical teratoid/rhabdoid tumors: the need for more active therapeutic measures in younger patients. J Neuro-Oncol. 2012;107(2):413–9.

3. Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, Rorke-Adams LB, Fisher MJ, Janss A, Mazewski C, et al. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol. 2009;27(3):385–9.

4. Lafay-Cousin L, Hawkins C, Carret AS, Johnston D, Zelcer S, Wilson B, Jabado N, Scheinemann K, Eisenstat D, Fryer C, et al. Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric brain tumour consortium experience. Eur J Cancer. 2012;48(3):353–9.

5. Hasselblatt M, Isken S, Linge A, Eikmeier K, Jeibmann A, Oyen F, Nagel I, Richter J, Bartelheim K, Kordes U, et al. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors. Genes Chromosomes Cancer. 2013;52(2):185–90.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer Treatment;Cancer Research;2023-03-06

2. Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume;CNS Neuroscience & Therapeutics;2023-02-21

3. Human Malignant Rhabdoid Tumor Antigens as Biomarkers and Potential Therapeutic Targets;Cancers;2022-07-28

4. The identification of miRNA and mRNA expression profiles associated with pediatric atypical teratoid/rhabdoid tumor;BMC Cancer;2022-05-06

5. High expression of NPM1 via the Wnt/β‐catenin signalling pathway might predict poor prognosis for patients with prostate adenocarcinoma;Clinical and Experimental Pharmacology and Physiology;2022-02-14